Increasing evidence for involvement of SV40 in human cancer

Disease Markers

Volumn 17, Issue 3, 2001, Pages 167-172

  Butel, J S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ASTROCYTOMA; BK VIRUS; BRAIN CANCER; CARCINOGENESIS; CARCINOMA; CHOROID PLEXUS TUMOR; CHROMOSOME MICRODISSECTION; CONTAMINATION; EPENDYMOMA; GENE CONSTRUCT; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; JC VIRUS; NONHUMAN; ONCOVIRINAE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; SOUTHERN BLOTTING; VIRUS INHIBITION; VIRUS ISOLATION; WESTERN BLOTTING;

BK POLYOMAVIRUS; DNA VIRUSES; JC VIRUS; ONCOVIRINAE; SIMIAE; SIMIAN VIRUS 40;

EID: 0035663146     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/857621     Document Type: Review

References (55)

1. SV40 and human tumors
2. BK and JC human polyomaviruses and simian virus 40: Natural history of infection in humans, experimental oncogenicity, and association with human tumors
3. D.N.A. sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood
4. Simian virus 40 (Papovaviridae)
5. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease
6. Molecular evidence of simian virus 40 infections in children
7. Evidence of SV40 infections in hospitalized children
8. Cell and molecular biology of simian virus 40: Implications for human infections and disease
9. Simian virus-40 large-T antigen binds p53 in human mesotheliomas
10. Simian virus 40, poliovaccines and human tumors: A review of recent developments
11. Polyomavirinae: The viruses and their replication
12. SV40 large T-antigen and human pleural mesothelioma: Screening by polymerase chain reaction and tyramine-amplified immunohisto-chemistry
13. Simian Virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey
14. Cancer risk associated with simian virus 40 contaminated polio vaccine
15. An evaluation of the carcinogenicity of simian virus 40 in man
16. SV40 and human brain tumors
17. Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40
18. SV40 in human brain tumors: Risk factor or passenger?
19. Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines
20. SV40 neutralizing antibodies in the sera of man and experimental animals
21. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen
22. Papovavirus-related RNA sequences in human neurogenic tumours
23. The human polyomaviruses, BKV and JCV: Molecular pathogenesis of acute disease and potential role in cancer
24. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults
25. Association of SV40 with human tumours
26. Episomal simian virus 40 genomes in human brain tumors
27. Cloning of SV40 genomes from human brain tumors
28. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas
29. Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens
30. Polyomaviruses and human tumors: A brief review of current concepts and interpretations
31. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors
32. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes
33. + patients
34. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals
35. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine
36. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates
37. Simian virus 40 and human pleural mesothelioma
38. More about: Cell and molecular biology of simian virus 40: Implications for human infections and disease
39. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: No impact on cancer incidence rates 1960 to 1993
40. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma
41. Human exposure to SV40: Review and comment
42. Evidence for an SV40-related papovavirus infection of man
43. Does SV40 infection contribute to the development of human cancers?
44. SV40 neutralizing antibodies in sera of US residents without history of polio immunization
45. Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas
46. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations
47. Identification of a variable region at the carboxy terminus of SV40 large T-antigen
48. Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans
49. Simian virus 40 and pleural mesothelioma in humans
50. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates
51. Detection of SV40 T antigen genome in human gliomas
52. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas
53. Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas
54. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors
55. Quantitative determination of papovavirus IgG antibodies in sera from cancer patients, labworkers and several groups of control persons by enzyme-linked immunosorbent assay (ELISA)